低分子肝素对下肢骨科术后患者von Willebrand因子和α颗粒膜蛋白140的干预作用
!"#$%&'()*+,-.!"#!/ $01 %21 &3 '()* + ',)- '.,/ 0/1 234/5-,6*)5 31)-)6*78 9:;:64? %8 @6? &
ABCD ="? E$FFG 5H.? I? )?&=@A
BCDB
EF,GHIJK@ALMNO5 L6* M)44/N,.*1
P,Q !RSTUV =&KWXY4Z
!"#
!"#$ %& [\EF,GHIJK@ALMO5]^ L6* M)44/N,.*1P,*>MO.
Q !RSTUV =&K*P0Q!=&K.WXY4Z_`...
!"#$%&'()*+,-.!"#!/ $01 %21 &3 '()* + ',)- '.,/ 0/1 234/5-,6*)5 31)-)6*78 9:;:<- !"=!8 >64? %8 @6? &
ABCD ="? E$FFG 5H.? I? )<<*? =JF&!J$$K? !"=!? "&? ""%
45678E=!""" 9:;<'=>?&=@A
BCDB
EF,GHIJK@ALMNO5 L6* M)44/N,.*1
P,Q !RSTUV =&KWXY4Z
!"#
!"#$ %& [\EF,GHIJK@ALMO5]^ L6* M)44/N,.*1P,*>MO.
Q !RSTUV =&K*P0Q!=&K.WXY4Z_`abc '( d %KeJK@AfgO5
FhijkQIlkmnko !%ecpkO5qrstuW@AijQv
MOQ P0Q!=&Kmg
N1 F |Q1 =& |JK]JK ¡]¢
*A>R.c )* ijkQIlkt£mg¤]^ >MO Q P0Q!=&K ¥W£¦m§¨q©
ª«'¬*!q " K?K%.®gN1 =|ijk]^ >MOQ P0Q!=&K¯E°Ilkm±§¨
q©ª«'¬*!q " K?K%.c gN1 F|Q1 =&|ijk >MOq²³E°Ilk*" S
=E?=!JT?=JEm! q # K?K=®" S ==?F$%$?!T=m! q # K?K%.c pk´µ¶3·q¸¹º»
A>Rc )+ EF,G¼½EJK@AfgNO5]^ >MOQ P0Q!=&Km¾¿]
·ÀÁÂÃmĽE A>RW¹ÅÆÇc
,-./$ GmEF,® L6* M)44/N,.*1P,® !RSTUV =&K® JK@Afg
!""#$% &" '&( )&'*$+',- (*./0% 0*1,-.2 &2 %0* 3&2 4.''*5-627 "6$%&- 627 1'6%*'*%
6'106!/-62+'* )*)8-62* 1-&%*.2!9:; .2 1,%.#2%< (.%0 '&(#- '.)5 &-%0&1#=.> <+-/*-?
#$%& '()!*)+, -)./0"1)+" 23 %0"42.)5678 9336:6/")5 $2;.6"/: 23 <4/2=6+> &+6?)0;6"@8
<4/2=6+> ABCDDD8 E46+/
,@5<%-,>%$ A5B*>%.3* R6 )*L/<-);.-/ -(/ /UU/5- .*1 H/5(.*)MO7 .*1 -(/ W4.-/4/- .4W(.!;,.*:4/ H/HN,.*/ W,6-/)*!
#&K 2P0Q!#&K7 )* W.-)/*-< V)-( 46V/, 4)HN 6,-(6W/1)5 <:,;/,X? C*%0&7< O)U-X W.-)/*-<
:*1/,;6)*; 46V/, 4)HN 6,-(6W/1)5 <:,;/,X V/,/ ,.*16H4X 1)L)1/1 )*-6 -(/ -,/.-H/*- ;,6:W
2!% 5.<7 .*1 -(/ 56*-,64 ;,6:W 2!% 5.<7? R(/ W.-)/*-< )* -(/ -,/.-H/*- ;,6:W ,/5/)L/1
46V H64/5:4., V/);(- (/W.,)* 5.45):H NX (XW61/,H)5 )*I/5-)6* .- #! ( N/U6,/ <:,;/,X .*1
6*5/ 1.)4X U6, ## 1 .U-/, <:,;/,X8 V()4/ )* -(/ 56*-,64 ;,6:W W.-)/*-< ,/5/)L/1 /Y:)L.4/*-
.H6:*- 6U *6,H.4 <.4)*/ )*<-/.1? R(/ 4/L/4< 6U >MO .*1 P0Q!#&K V/,/ -/<-/1 N/U6,/ .*1
6* 1.X< #8 F8 .*1 #& .U-/, <:,;/,Xm.*1 1//W L/*6:< -(,6HN6<)< 2A>R7 V.< 1/-/5-/1 NX
5646, 16WW4/, :4-,.<6*6;,.W(X 6* F-( .*1 #&-( 1? D*<+'%< R(/,/ V/,/ *6 <-.-)<-)5.4
!B B
!"#$%&'()*+,-.!"#!/ $01 %21 &3 '()* + ',)- '.,/ 0/1 234/5-,6*)5 31)-)6*78 9:;:<- !"=!8 >64? %8 @6? &
1)AA/,/*5/< )* -(/ 4/B/4< 6A >CD .*1 E0F!#&G H/A6,/ -(/ <:,;/,I 2.44 ! " G?G%7? 9A-/, -(/
<:,;/,I8 -(/ 4/B/4< 6A >CD .*1 E0F!=&G )* -(/ -,/.-J/*- ;,6:K L/,/ <);*)A)5.*-4I 46L/, 6* M-(
.*1 =&-( 1 2" N #O?#!P8 Q?#PO8 .44 ! # G?G#4" N ##?M$%8 $?!Q#8 .44 ! # G?G%78 L()4/ <(6L/1 *6
<-.-)<-)5.4 1)AA/,/*5/< 6* #<- 1 L(/* 56JK.,/1 -6 -(6 )* -(/ 56*-,64 ;,6:K 2.44 ! " G?G%7? 944
K.-)/*-< )* -(/ -L6 ;,6:K< 1)1 *6- A)*1 R>S 6* M-( .*1 #&-( 1 .A-/, <:,;/,I? !"#$%&'(") S(/
T0CU )* K.-)/*-< L)-( 46L/, 4)JH 6,-(6K/1)5 <:,;/,I 56:41 1/5,/. -(/ 4/B/4< 6A >CD .*1
E0F!#&G8 ,/1:5/ -(/ /*16-(/4).4 5/44 1.J.;/ .*1 -(/ ,)S?
!*+, -"./'" U/K.,)*8 46L!J64/5:4.,!L/);(-W >6* C)44/H,.*1 A.5-6,W F4.-/4/- .4K(.!;,.*:4/
J/JH,.*/ K,6-/)*!=&"W T6L/, 4)JH 6,-(6K/1)5 <:,;/,I
56789:*;7<=>?@ABCDEFGH:.:IJKLMNOPQRST56U
VWXPYZ9:A[\]^_`ab%cdefaghijklmnopqAUrstuv
w\Pxyz{|}~56gU*1//K B/*6:< -(,6JH6<)S.aY
R>S
apPMaP^,STOP
$| _`¡¢P£$¤¥¦§¨© R>Saªf
X=!&Y
Urstuvw\oU«¬®
¯}°U±²³´aEµ¶·
B6* C)44/H,.*1,*B6* C)44/H,.*1 A.5-6,P>CD.¸ ¥U
rstuv!P¹stuvº»I^¼½¾¿ÀUÁ¯}°UcdPÂÃĽÅÆcdst
uvw\aÇÈÉÊ
X%!PY
!ËÌÍÎÏ =&"*K4.-/4/- .4K(.!;,.*:4/ J/JH,.*/ K,6-/)*!=&"PE0F!
=&".ÐÑ F!ÒÓP¸¥U«¬ostuv!P¹U«¬½®I½¾¿ÀUÔPÕstu
vw\I E0F!=&"¼Ö¥stuv×PØ|Ù¼¯}°UcdP£UÔ! E0F!=&"ÚÛ
¼cÜU«¬®Ý²ÛP½ÅÆxÞßàaU«¬®ÝÊ)á
XM!QY
âã,ä åæç°U,".o#.a®àPèçUªfoç°éêa
âã,ëaä
ꥨ©oìíUàP; R>SAAîïð¢ñ
78
9:!Pòó R>Sa{|Äôõzꨩö÷aâã,äÁøùúûüý
òóþÂaôõo¨©ö÷ÿP âã,äþ!"L#UÃ$o®Ý%ã°U®&Ã
$*.5-)B.-/1 K.,-).4 -(6JH6K4.<-)* -)J/P9FSS.P'(à)
*>Pâã,äoî
ïð¢aì+!¼ó >CDo E0F!=&",~-./
01Ø|¯}°Ucd!aEµé
êPå]âã,äì+o¨© R>Sa2zê!3a4ûüýP56789:;5
6789:I<=zêâã,äó{|UÔ >CDo E0F!=&"a./P >¶?@âã,
äUà!aì+ANoBC
0 #$%&'
010 ()#$ !""Q/ %0D !"=!/ !0EF78GFÁHI56789:a{| %"
JP^!DEFGH: =PJPBEFGH: =PJP567S
`aÊKLcdUeCþfgU«¬hieAjkUl{
|P°U&g®OÛ # P"[A#Umn|
oaÊKLâã,ä±ÇCpIàqPzê
±²!#U«¬8R5rC#f#Umn|
s¥âã,äó¨© R>Saftü
ýP567uvEwâã,äó56789:{|:IUÔ >CDo E0F!#&Ga./P#¥
!&!x x
!"#$%&'()*+,-.!"#!/ $01 %21 &3 '()* + ',)- '.,/ 0/1 234/5-,6*)5 31)-)6*78 9:;:<- !"=!8 >64? %8 @6? &
45'6&789:;<=>?!@ABC A>BDEFGHIBJKLMNOP@QRS6
TUV7W
!"# !"#$ J?XYZ[\Z,]^_*` abcd!efghijklmnop.qr
?6=>??j5
\Z,]^_W\Z,]^_6DEy<
C 1<¡¢ %" D;E "?! E4 F 1< %= G H" D;E "?C E4 F 1<£¢ H" D;E "?& E4 F 1<1 &¤w
[ "?& E4 F 1W ¥m¦§DEw[G¨©ªIJ6 K0L!=&MÀÁWZ¢
1 H61 =&ÃÄÅÆÇÈÉʽËDEÌ
ͼÎW
!"% ,-./0 ÏÐÑÒwÐ "ÓµÔ*!
!
" ".ÕÖ<y×ÐØ #½LPÃÙ
ÏZÚ< $ # "?"%[ÔÛÜmÙÏ'ÝÞW
# 12
ß?DEº»¼ >IJ6 K0L!=&"àxá<ÔÛwâÙÏ'ÝÞ
*% N M?=&C·M?MO&<$w $ M?M%.W
1 =IJ6 K0L!=&Màã\¢=
>?<äÔÛåwâÙÏ'ÝÞ*% N =?CC=·!?!!=<$w $M?M%.W
1 H61 =&IJ6 K0L!=&Màæç\¢=>?<ÔÛwmÙÏ'ÝÞ*% N =C?=!O·
P?=OC<$w # M?M=è% N ==?H$%·$?!P=<$w # M?M=.<éêÕ =W ë
1 H61 =&Bzîj%&³'ª
B¼()<äTé*+kM,Z-.W ú/6ß#0ô?12/63%45<67¼Îø
*82/M9îS¼:5<;TÍ{|ß<
Æ<=÷kH>Mnk?H<67
¼@ABBz()ùæ'ªW>IJ6 K0L!=&MwëS¼45!
¤$HI< ¼¿ >IJ àJ¼Îø*8O2üý6¼¡KLMNO\PQxR<
K0L!=&MSTU[¼òVW6¼òóôzÓ)"M#N:5¼¡K9?à<¶E
àXOSDEîj A>Bz()X£WYZz«¬[\Õù<Î]\Z,]^V7<ß
5 ! ¶?DEß
¼¿ >IJ6 K0L!=&Màz^_*!
!
% ".
? `Ó uÐ 1 = 1 H 1 =&
V7? >IJ**; F Q. %= " P OH " == CO " $
.
CO " %
.
K0L!=&M*!; F Q. ! H% " =M PM " $ OC " $
.
%H " P
.
=>? >IJ**; F Q. %! " $ H= " =M ! HM " =M OM " P
K0L!=&M*!; F Q. H% " P PO " =M !!$P " == ! $! " =!
! ! ! !a>IJaR6* I)44/S,.*1E,*R6* I)44/S,.*1 T.5-6,.èK0L!=&Ma"bcdef =&M*U4.-/4/- .4U(.!;,.*:4/ E/ES,.*/
U,6-/)*!=&M.èJy×=>?g_<
.
$ & M?M=
!%
!%
!%
!%
!&Ch h
!"#$%&'()*+,-.!"#!/ $01 %21 &3 '()* + ',)- '.,/ 0/1 234/5-,6*)5 31)-)6*78 9:;:<- !"=!8 >64? %8 @6? &
451 =678 >AB9 C0D!=&":;<=>?@A BCD4EFG7HIJKLMN97
OPQR:S?@ATUVW E>FXYZ[\]^_ `abcXdefgh,ijklm5
78 >AB9 C0D!#&G>ngop3qrs:;Aptuv]^wxyz{7[\ABC|}
~ E>FXlmf_
ij
Agh,ij78u!9Zf
@Aptq7!9]A".,Q]Aq7QgAuv>n
9DFF97t _ ¡¢£=gh,ij¤¥~ >AB¦AE >AB§¨
©|7OPXªfA «¬ >ABX7OP®¯ °±²R9³´7OPµ¶X
>AB·¸A¹ft
ijº»¼½ogh,ij¾¿À~Á+ÂAÃÄ7HÅ
JKLÆÇ]KLÅÈÉÊKLZ,QAËÌKLÍÎA« >ABX·¸
H=G!=!I
_ g
h,ijÃÄÏQRÉÊÐA¨©7OPÑZÒÓÔÕÖAg78 C0D!=&G×ØA¨
©7OPQ
H=J!=%I
_
¾¡¢£ÙVWÚÛD45wxJVbÜgh,ijkuv]^{7[\A ptEg
78 >AB9 C0D!=&G:SA«Ý7HÅJKLMÞAg§Y E>F[\_
! " # $
= ßàáAâãäAåæZAç? gh,ijèéêëìíD45VWîïð7ñòÈXó!ô¡¢? !
õÚÛ()A!GGKA!K*=!.ö$=L!$!!?
! ÷øù? gh,ijúûüýþèéÚÛ45îïð7ñòÈXÿ!"#? Å$%!&&A!GGLA!$
*=%.ö!$!!L?
J '()AâÌ*A+,-Aç? ./VWÚ045§Yîï1ñ2è34©XE5¡¢? 7ñ67
'A!GGKA=!*&.ö=&L!=%=?
& 78A9:;A<=Aç? gh,ijú>?@ABCèéÚÛ45VWîï17ñòÈ? DE&
'F'GA!GGLAJL*%.ö&MM!&ML?
% HIJ? KLôCMwxÅJNO9ÉPQXQRR|ST!ì¡¢? UfVWlX(
)A!GG$A!!*%.öJ%J!J%&?
K YZA[\;Aå]^Aç? 7NO_Q`VWîï17ñòÈ!Xa!cb? !õcV&'()A
!GG&A=J*J.ö=M!!=M&?
M NO,4/ D98 P,6* C8 3)5()*;/, Q8 /- .4? '),5:4.-)*; D!4/5-)* .*1 -(/ ,)8 N.)1/, 98 /- .4? D!4/5-)* ;/*/ (.Y46-OY/< U61:4.-/ <64:V4/ D!4/5-)* 56*5/*"
-,.-)6*< .*1 56*-,)V:-/ -6 -(/ ,)8 Q.)4/, F8 /- .4? P);( 56*5/*-,.-)6*< 6S <64:V4/ D!4/5-)* .,/ .<<65).-/1 Z)-(
,)64? %8 @6? &
-)6* A/B)* C(,6BD E/B6<-8 =F$$8 #& A:GG4H $$!#I%?
=J 4567896:;<6=? >?,@ABCDEFGHCIJKLMNOPQ? RSTU()6=FFF6=K
*!.VF!!FJ?
=& WX6YZ[6\]^6=? >?,@A_`abcdBefgMhij`kGHCIJlmOPQ? !
nj`RS6!II%6!=*&.V!$F!!FI?
=% opq6rst6unv6=? wCfxCyz{|}~CIJ
CL0M!=&I NO!K
? !nRS'()6!II#6#P*&.V!K%!!KP?
*V!I#!!IK!!#.
*qV.
!"#!"$%&'()*+,-./012 #$%"&'(()*+,%-3&4.56789 /01
:;<=>234567!"?@ABCD"EFGH&IJ81/8J9:0;G80/!809!
!&%
本文档为【低分子肝素对下肢骨科术后患者von Willebrand因子和α颗粒膜蛋白140的干预作用】,请使用软件OFFICE或WPS软件打开。作品中的文字与图均可以修改和编辑,
图片更改请在作品中右键图片并更换,文字修改请直接点击文字进行修改,也可以新增和删除文档中的内容。
[版权声明] 本站所有资料为用户分享产生,若发现您的权利被侵害,请联系客服邮件isharekefu@iask.cn,我们尽快处理。
本作品所展示的图片、画像、字体、音乐的版权可能需版权方额外授权,请谨慎使用。
网站提供的党政主题相关内容(国旗、国徽、党徽..)目的在于配合国家政策宣传,仅限个人学习分享使用,禁止用于任何广告和商用目的。